Bill C-13, the COVID-19 Emergency Response Act, was the Canadian government’s legislative response to the Coronavirus pandemic. In addition a host of economic measures, the bill included some unexpected patent law provisions designed to speed access to essential medicines, devices or treatments. Matthew Herder, the director of the Health Law Institute at Dalhousie University, joins the podcast discuss the new Canadian rules, the use of compulsory licensing to enhance access to medicines, and other innovative approaches to overcoming potential access barriers raised by intellectual property laws.
Recent Posts
Taking Stock of Bill C-34: Five Things to Know About the Government’s Plan for a Kids’ Social Media Ban, Mandated Age Verification, and AI Chatbot Rules 
The Exemption Illusion: Why the Government’s Plan to Fast Track Bill C-34’s Kids’ Social Media Ban Means No Standards, No Privacy Review, and No Enforcement 
Unpacking Bill C-34: My Appearance on the Globe and Mail’s The Decibel Podcast 
Liberal MP: Lawful Access “Has Nothing to Do With the Privacy of People and Their Information” 
The Law to Be Named Later: Bill C-34 Punts 50 Key Decisions to Cabinet and a Digital Safety Commission That Does Not Yet Exist
